CANNA HEMP X Trademark

Trademark Overview


On Monday, November 5, 2018, a trademark application was filed for CANNA HEMP X with the United States Patent and Trademark Office. The USPTO has given the CANNA HEMP X trademark a serial number of 88984136. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 25, 2023. This trademark is owned by Infused MFG, LLC. The CANNA HEMP X trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived ...
canna hemp x

General Information


Serial Number88984136
Word MarkCANNA HEMP X
Filing DateMonday, November 5, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, May 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Dietary supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Liquid nutritional supplement, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Medicated lip balm, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Nutritional supplements in lotion form sold as a component of nutritional skin care products, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing only naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Orally-ingestible medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of dietary or nutritional supplements, the foregoing products containing hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing, as an inactive ingredient, naturally-occurring trace levels of CBD, the aforesaid CBD being solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing only naturally-occurring trace amounts of CBD; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets, in the nature of OTC products, the foregoing products containing, as an inactive ingredient, hemp seed oil solely derived from Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis, and the foregoing products containing no CBD, and all the foregoing containing or derived from hemp solely with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis, and all the foregoing containing no CBD

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInfused MFG, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLas Vegas, NV 89117

Trademark Events


Event DateEvent Description
Friday, January 26, 2024WITHDRAWAL OF ATTORNEY GRANTED
Friday, January 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Friday, January 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 19, 2024TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Friday, January 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, May 25, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, May 25, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 31, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 31, 2022NON-FINAL ACTION WRITTEN
Monday, April 25, 2022DIVISIONAL PROCESSING COMPLETE
Wednesday, April 20, 2022DIVISIONAL REQUEST RECEIVED
Monday, April 25, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 20, 2022TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 21, 2021NON-FINAL ACTION E-MAILED
Thursday, October 21, 2021NON-FINAL ACTION WRITTEN
Wednesday, October 13, 2021ASSIGNED TO EXAMINER
Monday, May 24, 2021ASSIGNED TO EXAMINER
Tuesday, May 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 10, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 10, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, February 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020NON-FINAL ACTION E-MAILED
Thursday, November 12, 2020NON-FINAL ACTION WRITTEN
Wednesday, October 14, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, October 8, 2020DIVISIONAL REQUEST RECEIVED
Thursday, October 8, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, October 8, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 8, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, August 25, 2020DIVISIONAL PROCESSING COMPLETE
Wednesday, August 19, 2020DIVISIONAL REQUEST RECEIVED
Thursday, August 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 19, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 19, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 19, 2020TEAS REQUEST TO DIVIDE RECEIVED
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Thursday, January 23, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, January 23, 2020DIVISIONAL PROCESSING COMPLETE
Thursday, December 19, 2019DIVISIONAL REQUEST RECEIVED
Friday, January 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 14, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 13, 2020ASSIGNED TO LIE
Thursday, December 19, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 19, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 18, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 18, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 8, 2019WITHDRAWAL OF ATTORNEY GRANTED
Thursday, August 8, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Wednesday, June 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2019NON-FINAL ACTION WRITTEN
Wednesday, June 19, 2019ASSIGNED TO EXAMINER
Sunday, November 25, 2018ASSIGNED TO EXAMINER
Tuesday, November 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 9, 2018TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, November 9, 2018TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, November 8, 2018NEW APPLICATION ENTERED